ESCRS - PO245 - Bevacizumab Eye Drops Versus Intra-Meibomian Gland Injection Of Bevacizumab For Meibomian Gland Dysfunction

Bevacizumab Eye Drops Versus Intra-Meibomian Gland Injection Of Bevacizumab For Meibomian Gland Dysfunction

Published 2022 - 40th Congress of the ESCRS

Reference: PO245 | Type: Free paper | DOI: 10.82333/dn2a-tw71